PTC Therapeutics Q1 2022 Earnings Preview

May 02, 2022 5:45 PM ETPTC Therapeutics, Inc. (PTCT)By: Manshi Mamtora, CFA
  • PTC Therapeutics (NASDAQ:PTCT) is scheduled to announce Q1 earnings results on Tuesday, May 3rd, after market close.
  • The consensus EPS Estimate is -$1.66 and the consensus Revenue Estimate is $146.9M (+24.6% Y/Y).
  • Over the last 1 year, PTCT has beaten EPS estimates 0% of the time and has beaten revenue estimates 50% of the time.
  • Over the last 3 months, EPS estimates have seen 1 upward revision and 3 downward. Revenue estimates have seen 3 upward revisions and 2 downward.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.